Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRME
PRME
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRME News
Prime Medicine Wins Ruling, Boosts Stock Performance
2h ago
stocktwits
Prime Medicine Gains 8% After Arbitration Win Against Beam Therapeutics
6h ago
seekingalpha
PM359 Receives FDA RMAT Designation, Accelerating Gene Therapy Development
Jun 22 2026
Newsfilter
Investment Comparison: Ocular Therapeutix vs. Prime Medicine
Jun 15 2026
Fool
Avaí Bio Initiates Master Cell Bank Manufacturing
Apr 01 2026
Newsfilter
Avaí Bio Initiates Master Cell Bank Manufacturing
Apr 01 2026
PRnewswire
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
Mar 24 2026
PRnewswire
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
Mar 24 2026
Newsfilter
Prime Medicine Focuses on Liver Franchise with $191.4M Cash Runway
Mar 08 2026
Yahoo Finance
Prime Medicine Reports FY 2023 Financial Results
Mar 03 2026
seekingalpha
Prime Medicine Reports Q4 2025 Results and Future Milestones
Mar 03 2026
seekingalpha
Prime Medicine to Participate in Three Major Conferences
Feb 25 2026
Yahoo Finance
Avant Technologies Drives Gene Therapy Market to $36.55 Billion by 2032
Jan 02 2026
Newsfilter
Avant Technologies Drives Gene Therapy Market to $36.55 Billion by 2032
Jan 02 2026
PRnewswire
Prime Drink Group Closes $450,000 Non-Brokered Private Placement
Jan 01 2026
Globenewswire
PrimeDrink Group Plans Non-Brokered Private Placement to Raise Up to $5 Million
Dec 18 2025
Globenewswire
Show More News
